{
  "ticker": "OPL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959076",
  "id": "02959076",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250617",
  "time": "0911",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250617/pdf/06ktcv7rfghzzf.pdf",
  "summary": "- **Appointment Announcement**: Matt Hallam appointed as Chief Revenue Officer (CRO) of Opyl Limited, effective immediately.  \n- **Compensation**: AUD $10,000/month (70% cash, 30% equity via consulting agreement).  \n- **Impact**: Focused on accelerating commercial growth for TrialKey.ai in biopharmaceutical and clinical research sectors.  \n\n*No material trading or capital markets impact identified.*",
  "usage": {
    "prompt_tokens": 863,
    "completion_tokens": 88,
    "total_tokens": 951,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-16T23:32:12.617767"
}